Imaging synaptic density in the living human brain
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Synaptic density in the living human brain was measured with positron emission tomography and a synaptic vesicle glycoprotein 2A tracer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo imaging of synaptic density is now possible using PET and [ 11 C]UCB-J - a radioligand that binds to the synaptic vesicle protein 2A (SV2A) 41 .”
From Imaging the effect of ketamine on synaptic density (SV2A) in the living brain (2022) · cites this paper as [41]
In the citing paper
“the most common method to quantify synaptic density has been the quantification of pre-(e.g., synaptophysin [9], synapsin [8]) and post-synaptic (e.g., PSD-95 [10]) genes/proteins”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [9]
In the citing paper
“there was also good correlation between SV2A and the “gold standard” pre-synaptic density marker synaptophysin in western blot and confocal microscopy experiments”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [67]
In the citing paper
“Thus, it was decided that SV2A can be used as an alternative to synaptophysin for quantification of synapse density”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [67]
In the citing paper
“quantification of radiotracer binding to SV2A does correlate with measures of synaptic vesicle number [8,9,69,70] and expression of other pre-synaptic proteins classically used in postmortem and in vitro work (e.g., synaptophysin, synapsin).”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373 · cited 2×
“2 × 10(14) synapses per liter of brain tissue, as reported for the female human brain (42), and two to five SV2A copies per vesicle (31, 36), it can be estimated that there are 154 to 385 vesicles per synapse.”
BackgroundAzevedo, F. A. C., Carvalho, L. R. B., Grinberg, L. T., Farfel, J. M., Ferretti, R. E. L., Leite, R. E. P., Filho, W. J., Lent, R., & Herculano‐Houzel, S. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21974 · Cited by 2,337
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationDecreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · cited 1×
“Moreover, regional synaptic changes have been demonstrated in patients with autism (10), depression (11), or schizophrenia (12, 13).”
BackgroundWiedenmann, B., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,428 · cited 1×
“SYN is themost abundant synaptic vesicle protein (31) and is a widely used marker of synaptic density (32, 33), because it was one of the first characterized (29, 34) and cloned (35) vesicle membrane proteins.”
BackgroundLoss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
Tang, G., Gudsnuk, K., Kuo, S.-H., Cotrina, M. L., Rosoklija, G., Sosunov, A., Sonders, M. S., Kanter, E., Castagna, C., Yamamoto, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.040 · Cited by 1,146
Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size
Hoffman, E. J., Huang, S.-C., & Phelps, M. E. (1979) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-197906000-00001 · Cited by 1,143
Rizzoli, S. O., & Betz, W. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1583 · Cited by 975 · cited 1×
“This number is very similar to the previously reported 200 to 350 vesicles per active zone in rat cultured hippocampal preparations, Drosophila neuromuscular junctions, or rat calyx of Held terminals, although other species have higher numbers of vesicles (43).”
ResultQuantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Kang, H. J., Voleti, B., Hajszan, T., Rajkowska, G., Stockmeier, C. A., Licznerski, P., Lepack, A., Majik, M. S., Jeong, L. S., Banasr, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2886 · Cited by 808
Buckley, K., & Kelly, R. B. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.4.1284 · Cited by 712 · cited 1×
“Antibodies targeting key proteins located in the pre- or postsynaptic neurons, such as synaptophysin (SYN), which is present in the membrane of synaptic vesicles (14), are commonly used for immunohistochemical detection of synaptic elements.”
Navone, F., Jahn, R., Di Gioia, G., Stukenbrok, H., Greengard, P., & De Camilli, P. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2511 · Cited by 674
Synaptic development of the cerebral cortex: implications for learning, memory and mental illness
(1994) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60543-9 · Cited by 565
De Camilli, P., Harris, S. M., Huttner, W. B., & Greengard, P. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.5.1355 · Cited by 532
Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging
Wu, Y., & Carson, R. E. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200212000-00004 · Cited by 449 · cited 2×
“BPND maps were generated with the simplified reference tissue model 2 (24) using the centrum semiovale as a reference brain region for nondisplaceable binding.”
MethodSelf-citationDifferential expression of synaptic vesicle protein 2 (SV2) isoforms
Bajjalieh, S., Frantz, G., Weimann, J., McConnell, S., & Scheller, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05223.1994 · Cited by 440
Synaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432
Carson, R. E., Channing, M. A., Blasberg, R. G., Dunn, B. B., Cohen, R. M., Rice, K. C., & Herscovitch, P. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.6 · Cited by 375
Self-citationFyn inhibition rescues established memory and synapse loss in Alzheimer mice
Kaufman, A. C., Salazar, S. V., Haas, L. T., Yang, J., Kostylev, M. A., Jeng, A. T., Robinson, S. A., Gunther, E. C., van Dyck, C. H., Nygaard, H. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24394 · Cited by 314 · cited 1×
“The relevance of SV2A as a synaptic marker was recently exemplified in a study inwhich the FYN tyrosine kinase inhibitorAZD0530 rescued both memory and synapse (SV2A) loss in a mouse model of Alzheimer’s disease (37).”
BackgroundBioImage Suite: An integrated medical image analysis suite: An update
Papademetris, X., Jackowski, M., Rajeevan, N., DiStasio, M., Okuda, H., Constable, R. T., & Staib, L. (2006) · The Insight Journal · doi:10.54294/2g80r4 · Cited by 298
Nabulsi, N. B., Mercier, J., Holden, D., Carré, S., Najafzadeh, S., Vandergeten, M.-C., Lin, S.-F., Deo, A., Price, N., Wood, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168179 · Cited by 296 · cited 4×
“PET measurements in human subjects [(11)C]UCB-J was synthesized at the Yale PET Center as previously reported (16).”
BackgroundMethodResultInfluentialSelf-citationMasliah, E., Terry, R. D., Alford, M., & DeTeresa, R. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.6.2110586 · Cited by 267
Carson, R. E., Barker, W. C., Liow, J.-S., & Johnson, C. A. (2004) · 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515) · doi:10.1109/nssmic.2003.1352597 · Cited by 262 · cited 1×
“5, 3 × 1, 2 × 2, and 22 × 5 min) with corrections for attenuation, normalization, scatter, randoms, and dead time using the MOLAR algorithm (51).”
MethodSelf-citationGillard, M., Fuks, B., Leclercq, K., & Matagne, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.064 · Cited by 253
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · cited 1×
“We demonstrate feasibility in epilepsy, but the application of SV2A-PET imaging as a synaptic marker may be particularly relevant to Alzheimer’s disease, in which the pathology is characterizedby accumulationofmisfoldedproteins (plaques composedof amyloid b, and Tau-containing neurofibrillary tangles) and synaptic los…”
BackgroundPathology and pathophysiology of the amygdala in epileptogenesis and epilepsy
Aroniadou-Anderjaska, V., Fritsch, B., Qashu, F., & Braga, M. F. M. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.11.011 · Cited by 224 · cited 1×
“In two epilepsy patients, in addition to hippocampal synapse loss, there was asymmetry in the amygdala, consistent with previous reports that damage in the amygdala is present in a significant subpopulation of TLE patients (25).”
ResultColumn-switching HPLC for the analysis of plasma in PET imaging studies
Hilton, J., Yokoi, F., Dannals, R. F., Ravert, H. T., Szabo, Z., & Wong, D. F. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00125-6 · Cited by 222
Gender differences in human cortical synaptic density
Alonso-Nanclares, L., Gonzalez-Soriano, J., Rodriguez, J. R., & DeFelipe, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803652105 · Cited by 210 · cited 1×
“2 × 10(14) synapses per liter of brain tissue, as reported for the female human brain (42), and two to five SV2A copies per vesicle (31, 36), it can be estimated that there are 154 to 385 vesicles per synapse.”
BackgroundSynaptophysin: molecular organization and mRNA expression as determined from cloned cDNA.
Leube, R. E., Kaiser, P., Seiter, A., Zimbelmann, R., Franke, W. W., Rehm, H., Knaus, P., Prior, P., Betz, H., & Reinke, H. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02644.x · Cited by 204 · cited 1×
“SYN is themost abundant synaptic vesicle protein (31) and is a widely used marker of synaptic density (32, 33), because it was one of the first characterized (29, 34) and cloned (35) vesicle membrane proteins.”
BackgroundMutch, S. A., Kensel-Hammes, P., Gadd, J. C., Fujimoto, B. S., Allen, R. W., Schiro, P. G., Lorenz, R. M., Kuyper, C. L., Kuo, J. S., Bajjalieh, S. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-10.2011 · Cited by 185
Expression of Synaptophysin During Postnatal Development of the Mouse Brain
Knaus, P., Betz, H., & Rehm, H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00754.x · Cited by 171 · cited 1×
“SYN is themost abundant synaptic vesicle protein (31) and is a widely used marker of synaptic density (32, 33), because it was one of the first characterized (29, 34) and cloned (35) vesicle membrane proteins.”
BackgroundComparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.
Savic, I., Ingvar, M., & Stone-Elander, S. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.6.615 · Cited by 159
Robinson, J. L., Molina-Porcel, L., Corrada, M. M., Raible, K., Lee, E. B., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2014) · Brain · doi:10.1093/brain/awu190 · Cited by 157
The Development, Past Achievements, and Future Directions of Brain PET
Jones, T., & Rabiner, E. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.20 · Cited by 155
Proper, E. A., Oestreicher, A. B., Jansen, G. H., Veelen, C. W. M. V., van Rijen, P. C., Gispen, W. H., & Graan, P. N. E. D. (2000) · Brain · doi:10.1093/brain/123.1.19 · Cited by 152
Gillard, M., Chatelain, P., & Fuks, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.022 · Cited by 148
van Vliet, E. A., Aronica, E., Redeker, S., Boer, K., & Gorter, J. A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01727.x · Cited by 147
Distribution of protein I in mammalian brain as determined by a detergent-based radioimmunoassay.
Goelz, S. E., Nestler, E. J., Chehrazi, B. B., & Greengard, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2130 · Cited by 108
Evaluation of18F-UCB-H as a Novel PET Tracer for Synaptic Vesicle Protein 2A in the Brain
Warnock, G. I., Aerts, J., Bahri, M. A., Bretin, F., Lemaire, C., Giacomelli, F., Mievis, F., Mestdagh, N., Buchanan, T., Valade, A., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.136143 · Cited by 85 · cited 1×
“[(18)F]UCB-H displayed good kinetics in rats (20) and nonhuman primates (21), and acceptable dosimetry in humans (22), but a human brain imaging study has not yet been reported.”
BackgroundSelf-citationMercier, J., Archen, L., Bollu, V., Carré, S., Evrard, Y., Jnoff, E., Kenda, B., Lallemand, B., Michel, P., Montel, F., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300482 · Cited by 77
Self-citationCrèvecœur, J., Kaminski, R. M., Rogister, B., Foerch, P., Vandenplas, C., Neveux, M., Mazzuferi, M., Kroonen, J., Poulet, C., Martin, D., et al. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12054 · Cited by 76
Levetiracetam: the first SV2A ligand for the treatment of epilepsy
Klitgaard, H., & Verdru, P. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.11.1537 · Cited by 75
Feng, G., Xiao, F., Lü, Y., Huang, Z., Yuan, J., Xiao, Z., Xi, Z., & Wang, X. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9288-2 · Cited by 74
[11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A
Estrada, S., Lubberink, M., Thibblin, A., Sprycha, M., Buchanan, T., Mestdagh, N., Kenda, B., Mercier, J., Provins, L., Gillard, M., et al. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.03.004 · Cited by 71
Self-citationPerdahl, E., Adolfsson, R., Alafuzoff, I. I., Albert, K. A., Nestler, E. J., Greengard, P., & Winblad, B. G. (1984) · Journal of Neural Transmission · doi:10.1007/bf01245030 · Cited by 67
Jin, X., Chan, C., Mulnix, T., Panin, V., Casey, M., Liu, C., & Carson, R. E. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/16/5567 · Cited by 63 · cited 1×
“Event-by-event motion correction (52) was included in the reconstruction on the basis of motion detection with a Polaris Vicra optical tracking system (NDI Systems) using reflectors mounted on a swim cap worn by the subject.”
MethodSelf-citationBinding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain
Gillard, M. R., Fuks, B., Michel, P., Vertongen, P., Massingham, R., & Chatelain, P. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.032 · Cited by 61 · cited 1×
“Mean cortical Bmax values in baboonwere 18 pmol/mg protein, somewhat higher than the values of 3 to 12 pmol/mg protein in rats (39, 40) and 3 to 4 pmol/mg protein in Fig.”
BackgroundGallezot, J., Zheng, M., Lim, K., Lin, S.-F., Labaree, D. C., Matuskey, D., Huang, Y. H., Ding, Y., Carson, R. E., & Malison, R. T. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132928 · Cited by 57
Self-citationBretin, F., Bahri, M. A., Bernard, C., Warnock, G., Aerts, J. J., Mestdagh, N., Buchanan, T. J., Otoul, C., Koestler, F., Miévis, F., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0820-6 · Cited by 56
BioImage Suite: An integrated medical image analysis suite
Papademetris, X., Jackowski, M. P., Rajeevan, N., Constable, R. T., & Staib, L. H. (2005) · The Insight Journal · doi:10.54294/vb5z20 · Cited by 47
Test–retest reliability of [11C]AZ10419369 binding to 5-HT1B receptors in human brain
Nord, M., Finnema, S. J., Schain, M., Halldin, C., & Farde, L. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2529-1 · Cited by 36
Self-citationSandiego, C. M., Weinzimmer, D. P., & Carson, R. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.051 · Cited by 30
Self-citationFirst-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430
Naganawa, M., Waterhouse, R. N., Nabulsi, N., Lin, S.-F., Labaree, D. C., Ropchan, J. R., Tarabar, S., DeMartinis, N. A., Ogden, A. G., Banerjee, A., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166850 · Cited by 28
Self-citationZheng, M., Holden, D., Nabulsi, N., Lin, S.-F., Mercier, J., Hannestad, J. O., Laruelle, M. A., Carson, R. E., & Huang, Y. H. (2014) · Journal of Nuclear Medicine · Cited by 7
Self-citation
Research works printed but not linked: 1
- 10.1097/01.wcb.0000033967.83623.34 · doi:10.1097/01.wcb.0000033967.83623.34 · Paper page
Cited by
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803
“176,177 A future direction for the field could be to identifymorespecificrolesthatvarioussynapticbiomarkerscouldplay and possibly to break out synaptic biomarkers from the broader N category.”
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804766-8.00013-3 · Cited by 783
Protein misfolding in neurodegenerative diseases: Implications and strategies
Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0077-5 · Cited by 675
“now being developed in humans, and could be reversetranslated for use in rodent studies [127].”
Background
Metadata
- Authors
- Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., Spencer, D. D., Mercier, J., Hannestad, J., Huang, Y., & Carson, R. E.
- Affiliations
- Yale University (US)
- UCB Pharma (Belgium) (BE)
- Corresponding author
- Finnema, Sjoerd J.
- Hannestad, Jonas
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-07-20
- Volume
- 8
- Issue
- 348
- Pages
- 348ra96-348ra96
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2503767557
- Cited by
- 575
- References
- 59
- Citations by year
- 2026: 52 · 2025: 70 · 2024: 81 · 2023: 54 · 2022: 92 · 2021: 67 · 2020: 54 · 2019: 43 · 2018: 23 · 2017: 31 · 2016: 6
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swebilius Foundation
- UCB Pharma
- Swedish Research Council
- National Center for Advancing Translational Science (UL1 TR000142)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- synaptic density, SV2A, positron emission tomography, presynaptic terminals, synaptophysin, temporal lobe epilepsy, synaptic loss, Alzheimer's disease, neuroimaging
- MeSH terms
- Adult, Aged, Brain, Epilepsy, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Synapses, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.